A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis.

Bhattacharjee PS, Huq TS, Mandal TK, Graves RA, Muniruzzaman S, Clement C, McFerrin HE, Hill JM. A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis. PLoS One. 2011 Jan 06; 6(1):e15905.

View in: PubMed

subject areas

Animals
Antineoplastic Agents
Apolipoproteins E
Cell Movement
Cell Proliferation
Dipeptides
Endothelium, Vascular
Eye
Humans
Mice
Neovascularization, Pathologic
Peptide Fragments
Rabbits
Umbilical Veins

authors with profiles

Partha Bhattacharjee
Harris McFerrin
Syed Muniruzzaman
Tarun Mandal

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support